Propanolamine derivative having 1, 4-benzodioxane ring
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 4, 2006
Grant Date -
Nov 25, 2004
app pub date -
Sep 13, 2001
filing date -
Aug 10, 2000
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
This invention relates to a medicament containing as an active ingredient, a novel propanolamine having a 1,4-benzodioxane ring or a pharmaceutically acceptable salt thereof: ##STR1## The present compound is represented by the above formula wherein R1-3 may be the same or different and each represents a hydrogen atom, a halogen atom, a hydroxy group, a (C1-C6)alkyl group, a (C1-C6)alkoxy group, a (C1-C6)alkylsulfonamido group, or a phenyl group; R4-5 each represents a hydrogen atom or a (C1-C6)alkyl group; and A represents any of a benzene ring, a pyridine ring and a pyrimidine ring. This compound is useful as a prophylactic or therapeutic agent for diabetes, obesity, hyperlipemia, depression, a respiratory disease, or a gastrointestinal disease.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully